Bristol Myers Squibb Awards Nearly $8 Million in New Health Equity Grants to Improve Access to Care for Medically Underserved Patients in U.S. Pharmaceutical Investing
ADDING and REPLACING Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021 Pharmaceutical Investing
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021 Pharmaceutical Investing
AMGEN AND PLEXIUM ANNOUNCE MULTI-YEAR, DRUG DISCOVERY COLLABORATION TO IDENTIFY NOVEL TARGETED PROTEIN DEGRADATION THERAPIES Market News
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference Pharmaceutical Investing
BioHarvest Sciences Inc. to Present at BIO CEO & Investor Conference in New York City on February 14-17, 2022 Biotech Investing
